» Articles » PMID: 30181320

Cancer Progress and Priorities: Uterine Cancer

Overview
Date 2018 Sep 6
PMID 30181320
Citations 30
Authors
Affiliations
Soon will be listed here.
Citing Articles

Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021.

Sun P, Yu C, Yin L, Chen Y, Sun Z, Zhang T EClinicalMedicine. 2024; 74:102713.

PMID: 39050105 PMC: 11268131. DOI: 10.1016/j.eclinm.2024.102713.


Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy.

Bostan I, Mihaila M, Roman V, Radu N, Neagu M, Bostan M Cancers (Basel). 2024; 16(11).

PMID: 38893147 PMC: 11171255. DOI: 10.3390/cancers16112027.


Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection.

Galant N, Krawczyk P, Monist M, Obara A, Gajek L, Grenda A Int J Mol Sci. 2024; 25(11).

PMID: 38892080 PMC: 11172295. DOI: 10.3390/ijms25115893.


Epidemiology of Uterine Cancer in Sarawak, Borneo, A 20-Year Review.

Jawa D, Wong K, Wahab M, Azhar A, Fong E, Joseph E Asian Pac J Cancer Prev. 2024; 25(4):1143-1153.

PMID: 38679973 PMC: 11162726. DOI: 10.31557/APJCP.2024.25.4.1143.


Perceptions of a comprehensive physical activity behavior intervention among endometrial cancer survivors with obesity. A qualitative study.

Rossi A, Rossi M, Torres-Panchame R, Heyman N, Garber C, Nevadunsky N Gynecol Oncol Rep. 2023; 50:101313.

PMID: 38088957 PMC: 10714227. DOI: 10.1016/j.gore.2023.101313.


References
1.
Martinez-Garcia E, Lopez-Gil C, Campoy I, Vallve J, Coll E, Cabrera S . Advances in endometrial cancer protein biomarkers for use in the clinic. Expert Rev Proteomics. 2017; 15(1):81-99. DOI: 10.1080/14789450.2018.1410061. View

2.
Win A, Reece J, Ryan S . Family history and risk of endometrial cancer: a systematic review and meta-analysis. Obstet Gynecol. 2015; 125(1):89-98. DOI: 10.1097/AOG.0000000000000563. View

3.
Poole E, Lin W, Kvaskoff M, De Vivo I, Terry K, Missmer S . Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Cancer Causes Control. 2017; 28(5):437-445. PMC: 5410866. DOI: 10.1007/s10552-017-0856-4. View

4.
Sherman M, Sturgeon S, Brinton L, Potischman N, Kurman R, Berman M . Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol. 1997; 10(10):963-8. View

5.
Setiawan V, Yang H, Pike M, McCann S, Yu H, Xiang Y . Type I and II endometrial cancers: have they different risk factors?. J Clin Oncol. 2013; 31(20):2607-18. PMC: 3699726. DOI: 10.1200/JCO.2012.48.2596. View